Methylene Blue Inhibits Cromakalim-Activated K+ Currents in Follicle-Enclosed Oocytes

The effects of methylene blue (MB) on cromakalim-induced K+ currents were investigated in follicle-enclosed Xenopus oocytes. In concentrations ranging from 3–300 μM, MB inhibited K+ currents (IC50: 22.4 μM) activated by cromakalim, which activates KATP channels. MB inhibited cromakalim-activated K+ currents in a noncompetitive and voltage-independent manner. The respective EC50 and slope values for cromakalim-activation of K+ currents were 194 ± 21 µM and 0.91 for controls, and 206 ± 24 µM and 0.87 in the presence of 30 μM MB. The inhibition of cromakalim-induced K+ currents by MB was not altered by pretreatment with the Ca2+ chelator BAPTA, which suggests that MB does not influence Ca2+-activated second messenger pathways. K+ currents mediated through a C-terminally deleted form of Kir6.2 (KirΔC26), which does not contain the sulfonylurea receptor, were still inhibited by MB, indicating direct interaction of MB with the channel-forming Kir6.2 subunit. The binding characteristics of the KATP ligand [3H]glibenclamide are not altered by MB in a concentration range between 1 μM-1 mM, as suggested by radioligand binding assay. The presence of a membrane permeable cGMP analogue (8-Br-cGMP, 100 µM) and a guanylate cyclase activator (BAY 58-2667, 3 µM) did not affect the inhibitory effects of MB, suggesting that MB does not inhibit cromakalim-activated K+ currents through guanylate cyclase. Collectively, these results suggest that MB directly inhibits cromakalim-activated K+ currents in follicular cells of Xenopus oocytes.

[1]  A. Tinker,et al.  ATP-Sensitive Potassium Channels and Their Physiological and Pathophysiological Roles. , 2018, Comprehensive Physiology.

[2]  A. M. Mata,et al.  Methylene blue activates the PMCA activity and cross-interacts with amyloid β-peptide, blocking Aβ-mediated PMCA inhibition , 2018, Neuropharmacology.

[3]  C. Nichols Adenosine Triphosphate-Sensitive Potassium Currents in Heart Disease and Cardioprotection. , 2016, Cardiac electrophysiology clinics.

[4]  Hussein N. Rubaiy The therapeutic agents that target ATP-sensitive potassium channels , 2016, Acta pharmaceutica.

[5]  L. Tretter,et al.  Enhanced hydrogen peroxide generation accompanies the beneficial bioenergetic effects of methylene blue in isolated brain mitochondria. , 2014, Free radical biology & medicine.

[6]  M. Oz,et al.  Methylene blue inhibits the function of α7-nicotinic acetylcholine receptors. , 2012, CNS & neurological disorders drug targets.

[7]  T. Shippenberg,et al.  Methylene blue inhibits function of the 5‐HT transporter , 2012, British journal of pharmacology.

[8]  M. Oz,et al.  Cellular and molecular actions of Methylene Blue in the nervous system , 2011, Medicinal research reviews.

[9]  D. Lavigne Vasopressin and Methylene Blue: Alternate Therapies in Vasodilatory Shock , 2010, Seminars in cardiothoracic and vascular anesthesia.

[10]  M. Oz,et al.  Methylene blue and Alzheimer's disease. , 2009, Biochemical pharmacology.

[11]  P. Gillman,et al.  Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction , 2007, British journal of pharmacology.

[12]  T. Shippenberg,et al.  The Endogenous Cannabinoid Anandamide Inhibits Cromakalim-Activated K+ Currents in Follicle-Enclosed Xenopus Oocytes , 2007, Journal of Pharmacology and Experimental Therapeutics.

[13]  T. Küçükkılınç,et al.  Multi-site inhibition of human plasma cholinesterase by cationic phenoxazine and phenothiazine dyes. , 2007, Archives of biochemistry and biophysics.

[14]  U. Demirkılıç,et al.  Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery. , 2005, The Annals of thoracic surgery.

[15]  J. Wood,et al.  Effects of methylene blue on electrical behavior of myenteric neurons , 1985, Experientia.

[16]  R. Mannhold KATP channel openers: Structure‐activity relationships and therapeutic potential , 2004, Medicinal research reviews.

[17]  R. Levin,et al.  Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery. , 2004, The Annals of thoracic surgery.

[18]  T. Shippenberg,et al.  Cocaine inhibits cromakalim-activated K+ currents in follicle-enclosed Xenopus oocytes , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[19]  W. Rosenblum ATP-Sensitive Potassium Channels in the Cerebral Circulation , 2003, Stroke.

[20]  M. Oz,et al.  Direct noncompetitive inhibition of 5-HT(3) receptor-mediated responses by forskolin and steroids. , 2002, Archives of biochemistry and biophysics.

[21]  J. Stasch,et al.  NO‐ and haem‐independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle , 2002, British journal of pharmacology.

[22]  M. Wainwright,et al.  Methylene Blue - a Therapeutic Dye for All Seasons? , 2002, Journal of chemotherapy.

[23]  M. Oz,et al.  Inhibition of cromakalim-activated K+ current by ethanol in follicle-enclosed Xenopus oocytes , 2002, Naunyn-Schmiedeberg's Archives of Pharmacology.

[24]  F. Reimann,et al.  Pharmacological modulation of KATP channels , 2001 .

[25]  F. Ashcroft,et al.  New windows on the mechanism of action of K(ATP) channel openers. , 2000, Trends in pharmacological sciences.

[26]  F. Ashcroft,et al.  The antimalarial agent mefloquine inhibits ATP‐sensitive K‐channels , 2000, British journal of pharmacology.

[27]  M. Morad,et al.  Functional coupling of human L-type Ca2+ channels and angiotensin AT1A receptors coexpressed in xenopus laevis oocytes: involvement of the carboxyl-terminal Ca2+ sensors. , 1998, Molecular pharmacology.

[28]  C. Pang,et al.  Pressor and vasoconstrictor effects of methylene blue in endotoxaemic rats , 1998, Naunyn-Schmiedeberg's Archives of Pharmacology.

[29]  M. Sunagawa,et al.  ATP-sensitive K+ channels in pancreatic, cardiac, and vascular smooth muscle cells. , 1998, American journal of physiology. Cell physiology.

[30]  M. Kress,et al.  Methylene blue induces ongoing activity in rat cutaneous primary afferents and depolarization of DRG neurons via a photosensitive mechanism , 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.

[31]  R. Fischmeister,et al.  Methylene blue is a muscarinic antagonist in cardiac myocytes. , 1997, Molecular pharmacology.

[32]  F. Ashcroft,et al.  Truncation of Kir6.2 produces ATP-sensitive K+ channels in the absence of the sulphonylurea receptor , 1997, Nature.

[33]  Y. Nakaoka,et al.  The Photodynamic Action of Methylene Blue on the Ion Channels of Paramecium Causes Cell Damage , 1997, Photochemistry and photobiology.

[34]  J. Stockand,et al.  Activation by methylene blue of large Ca(2+)-activated K+ channels. , 1996, Biochimica et biophysica acta.

[35]  R. Miledi,et al.  Ion channels and membrane receptors in follicle-enclosed Xenopus oocytes. , 1996, Ion channels.

[36]  P. Nanasi,et al.  Effects of methylene blue and ascorbate on transmembrane potential in frog skeletal muscle. , 1995, General pharmacology.

[37]  M. Oz,et al.  Potentiation of 5-HT3 receptor-mediated responses by protein kinase C activation. , 1995, Neuroreport.

[38]  Y. Lee,et al.  Methylene blue induces cytotoxicity in human brain tumor cells. , 1995, Cancer letters.

[39]  M. Lazdunski,et al.  Functional receptors in Xenopus oocytes for U-37883A, a novel ATP-sensitive K+ channel blocker: comparison with rat insulinoma cells. , 1994, Molecular pharmacology.

[40]  U. Quast,et al.  Cellular pharmacology of potassium channel openers in vascular smooth muscle. , 1994, Cardiovascular research.

[41]  K. Okamoto,et al.  Atrial natriuretic factor potentiates glibenclamide-sensitive K+ currents via the activation of receptor guanylate cyclase in follicle-enclosed Xenopus oocytes. , 1994, European journal of pharmacology.

[42]  I. Yoneda,et al.  Inhibition by SKF 525A and quinacrine of endogenous glibenclamide-sensitive K+ channels in follicle-enclosed Xenopus oocytes. , 1994, European journal of pharmacology.

[43]  H. Sakuta Inhibition by histamine H1 receptor antagonists of endogenous glibenclamide-sensitive K+ channels in follicle-enclosed Xenopus oocytes. , 1994, European journal of pharmacology.

[44]  B. Yeğen,et al.  Effect of Methylene Blue on Blood Pressure in Rats , 1993 .

[45]  G. Edwards,et al.  The pharmacology of ATP-sensitive potassium channels. , 1993, Annual review of pharmacology and toxicology.

[46]  K. Okamoto,et al.  Modification by cGMP of glibenclamide-sensitive K+ currents in Xenopus oocytes. , 1993, Japanese journal of pharmacology.

[47]  K. Okamoto,et al.  Inactivation of glibenclamide-sensitive K+ channels in Xenopus oocytes by various calmodulin antagonists. , 1992, European journal of pharmacology.

[48]  M. Lazdunski,et al.  Hormone-regulated K+ channels in follicle-enclosed oocytes are activated by vasorelaxing K+ channel openers and blocked by antidiabetic sulfonylureas. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[49]  M. Lazdunski,et al.  Chlorpromazine and related phenothiazines inhibit the ATP-sensitive K+ channel. , 1991, European journal of pharmacology.

[50]  L. Thuneberg Methylene blue as a pharmacological probe of intestinal pacemaker activity. , 1990, The American journal of physiology.

[51]  T. Sakai Acetylcholine induces Ca-dependent K currents in rabbit endothelial cells. , 1990, Japanese journal of pharmacology.

[52]  K. Sanders,et al.  Effects of methylene blue on rhythmic activity and membrane potential in the canine proximal colon. , 1989, The American journal of physiology.

[53]  N. Dascal,et al.  The use of Xenopus oocytes for the study of ion channels. , 1987, CRC critical reviews in biochemistry.

[54]  L. Ignarro,et al.  Dissimilarities between methylene blue and cyanide on relaxation and cyclic GMP formation in endothelium-intact intrapulmonary artery caused by nitrogen oxide-containing vasodilators and acetylcholine. , 1986, The Journal of pharmacology and experimental therapeutics.

[55]  R. Miledi,et al.  Chloride current induced by injection of calcium into Xenopus oocytes. , 1984, The Journal of physiology.

[56]  J. Starkus,et al.  Kinetic analysis of sodium channel block by internal methylene blue in pronased crayfish giant axons. , 1984, Biophysical journal.

[57]  L. Ignarro,et al.  Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrite, and amyl nitrite. , 1981, Canadian journal of physiology and pharmacology.